Literature DB >> 15255932

Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-beta peptides via p75NTR/PLAIDD.

Yuichi Hashimoto1, Yuka Kaneko, Emi Tsukamoto, Harald Frankowski, Keisuke Kouyama, Yoshiko Kita, Takako Niikura, Sadakazu Aiso, Dale E Bredesen, Masaaki Matsuoka, Ikuo Nishimoto.   

Abstract

One of the most important pathological features of Alzheimer's disease (AD) is extracellular senile plaques, whose major component is amyloid-beta peptides (Abeta). Abeta binds to the extracellular domain of p75NTR (p75 neurotrophin receptor) and induces neuronal cell death. We investigated the molecular mechanism of Abeta-induced neurotoxicity in detail from the standpoint of interaction between p75NTR and its recently identified relative, PLAIDD (p75-like apoptosis-inducing death domain). Using F11 neuronal hybrid cells, we demonstrate that there are two distinct pathways for Abeta-induced toxicity mediated by p75NTR. One pathway that has been previously elucidated, is mediated by p75NTR, Go, JNK, NADPH oxidase and caspase3-related caspases. We found that PLAIDD and Gi proteins, heterotrimeric G proteins, are involved in the alternative Abeta-induced neurotoxicity mediated by p75NTR. The alternative pathway triggered by Abeta is thus mediated by p75NTR, PLAIDD, Gi, JNK, NADPH oxidase and caspase3-related caspases. In addition, we found that HN, ADNF, IGF-I, or bFGF inhibits both pathways of Abeta-induced neurotoxicity mediated by p75NTR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255932     DOI: 10.1111/j.1471-4159.2004.02513.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

Review 1.  Current therapeutic targets for the treatment of Alzheimer's disease.

Authors:  Joshua D Grill; Jeffrey L Cummings
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 2.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

3.  Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity.

Authors:  Nikolay L Malinin; Sarah Wright; Peter Seubert; Dale Schenk; Irene Griswold-Prenner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer's disease.

Authors:  Jessica Ciesler; Youssef Sari
Journal:  Open J Neurosci       Date:  2013-04-08

5.  p75 neurotrophin receptor mediates apoptosis in transit-amplifying cells and its overexpression restores cell death in psoriatic keratinocytes.

Authors:  F Truzzi; A Marconi; P Atzei; M C Panza; R Lotti; K Dallaglio; R Tiberio; E Palazzo; C Vaschieri; C Pincelli
Journal:  Cell Death Differ       Date:  2010-12-10       Impact factor: 15.828

6.  Interaction of ASK1 and the beta-amyloid precursor protein in a stress-signaling complex.

Authors:  Veronica Galvan; Surita Banwait; Patricia Spilman; Olivia F Gorostiza; Alyson Peel; Marina Ataie; Danielle Crippen; Wei Huang; Gurleen Sidhu; Hidenori Ichijo; Dale E Bredesen
Journal:  Neurobiol Dis       Date:  2007-07-03       Impact factor: 5.996

7.  The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo.

Authors:  Juliet K Knowles; Jayakumar Rajadas; Thuy-Vi V Nguyen; Tao Yang; Melburne C LeMieux; Lilith Vander Griend; Chihiro Ishikawa; Stephen M Massa; Tony Wyss-Coray; Frank M Longo
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

8.  Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130.

Authors:  Yuichi Hashimoto; Megumi Kurita; Sadakazu Aiso; Ikuo Nishimoto; Masaaki Matsuoka
Journal:  Mol Biol Cell       Date:  2009-04-22       Impact factor: 4.138

Review 9.  Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin.

Authors:  Tomohiro Chiba; Ikuo Nishimoto; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

10.  NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).

Authors:  Illana Gozes; Inna Divinski; Inbar Piltzer
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.